Dr. Uthayashanker Ezekiel is a Tenured Professor in the Department of Clinical Health Sciences at Saint Louis University's Doisy College of Health Sciences. His research focuses on cancer biology, epigenetics, and stem cell applications in neurodevelopmental disorders. He holds a Ph.D. in Microbiology from Saint Louis University, with postdoctoral training at Yale University and the University of Chicago. Education: Ph.D. in Microbiology, Saint Louis University Post-Doctoral Fellowship, Yale University Post-Doctoral Fellowship, University of Chicago Master of Science in Integrated Biology, Madurai Kamaraj University Bachelor of Science in Zoology, Madurai Kamaraj University Research Interests: His laboratory investigates mechanisms distinguishing normal and cancer cells, emphasizing phytochemical anti-cancer activities, epigenetic modulation (e.g., miRNA, histone modifications), and metastasis suppression. Recent work includes developing induced pluripotent stem cell (iPSC) models for neurodevelopmental disorders like autism and epilepsy, focusing on neuronal differentiation and disease pathogenesis. Labs & Teams: Dr. Ezekiel leads a multidisciplinary team advancing iPSC-based disease modeling and cancer epigenetics. Current projects include iPSC-derived neuronal models for CTBP1-related disorders and phytochemical targeting of chemoresistant cancers.













